Influence of drug lipophilicity on terpenes as transdermal penetration enhancers

被引:98
作者
Godwin, DA
Michniak, BB
机构
[1] Univ New Mexico, Hlth Sci Ctr, Coll Pharm, Albuquerque, NM 87131 USA
[2] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC 29208 USA
关键词
D O I
10.1081/DDC-100102251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Percutaneous absorption-enhancing effects on the skin of hairless mice of 11 monoterpenes [1, (+)-limonene; 2, (-)-menthone; 3, (+)-terpinen-4-ol; 4, alpha-terpineol; 5, 1,8- cineole; 6, (+)-carvone; 7, (-)-verbenone; 8, (-)-fenchone; 9, p-cymene; 10, (+)-neomenthol; and 11, geraniol] were investigated wing three different model drugs (caffeine, hydrocortisone, triamcinolone acetonide [TA]) with varying lipophilicities. Terpenes were applied at 0.4 M in propylene glycol (PG) to mouse skin. The model drugs were applied as suspensions in PG 1 hr following enhancer pretreatment. The combination of terpenes in PG provided significant enhancement of the permeation of caffeine through mouse skin. The most active compounds 10 and 11 increased permeation by between 13-fold and 16-fold. The terpenes also enhanced the delivery of hydrocortisone, but not to as great an extent. The most active compounds 3 and 4 increased permeation between 3.9-fold and 5-fold. The compounds examined did not significantly increase the delivery of TA. The most active compound 4 only increased delivery 2.5-fold, while the next most active compound 6 only increased delivery 1.7-fold. Overall, these results indicate that the combination of terpenes with PG can significantly increase the transdermal penetration of the hydrophilic drug caffeine and the polar steroid hydrocortisone.
引用
收藏
页码:905 / 915
页数:11
相关论文
共 31 条
[21]  
MICHNIAK BB, 1993, P 12 PHARM TECHN C, V2, P158
[22]   PERCUTANEOUS-ABSORPTION OF INDOMETHACIN FROM PLURONIC F127 GELS IN RATS [J].
MIYAZAKI, S ;
TOBIYAMA, T ;
TAKADA, M ;
ATTWOOD, D .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (06) :455-457
[23]  
OBATA Y, 1993, BIOL PHARM BULL, V16, P312
[24]  
OKABE H, 1992, CHEM PHARM BULL, V40, P1906
[25]   TRANSDERMAL DELIVERY OF DRUGS WITH DIFFERING LIPOPHILICITIES USING AZONE ANALOGS AS DERMAL PENETRATION ENHANCERS [J].
PHILLIPS, CA ;
MICHNIAK, BB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (12) :1427-1433
[26]   DRUG DELIVERY SYSTEMS .6. TRANSDERMAL DRUG DELIVERY [J].
RANADE, VV .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (05) :401-418
[27]   FDA AND AAPS REPORT OF THE WORKSHOP ON PRINCIPLES AND PRACTICES OF INVITRO PERCUTANEOUS PENETRATION STUDIES - RELEVANCE TO BIOAVAILABILITY AND BIOEQUIVALENCE [J].
SKELLY, JP ;
SHAH, VP ;
MAIBACH, HI ;
GUY, RH ;
WESTER, RC ;
FLYNN, G ;
YACOBI, A .
PHARMACEUTICAL RESEARCH, 1987, 4 (03) :265-267
[28]   THE ENHANCEMENT INDEX CONCEPT APPLIED TO TERPENE PENETRATION ENHANCERS FOR HUMAN SKIN AND MODEL LIPOPHILIC (ESTRADIOL) AND HYDROPHILIC (5-FLUOROURACIL) DRUGS [J].
WILLIAMS, AC ;
BARRY, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (2-3) :157-168
[29]   TERPENES AND THE LIPID PROTEIN PARTITIONING THEORY OF SKIN PENETRATION ENHANCEMENT [J].
WILLIAMS, AC ;
BARRY, BW .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :17-24
[30]   EFFECTS OF TERPENES AND OLEIC-ACID AS SKIN PENETRATION ENHANCERS TOWARDS 5-FLUOROURACIL AS ASSESSED WITH TIME - PERMEATION, PARTITIONING AND DIFFERENTIAL SCANNING CALORIMETRY [J].
YAMANE, MA ;
WILLIAMS, AC ;
BARRY, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (02) :237-251